Clinical Trials Logo

Clinical Trial Summary

The GILUPI CellCollector® is the first in vivo CTC isolation product worldwide which is CE approved. Application data of CellCollector in China is not available now. The purpose of this clinical trial is to confirm the validation and safety of CellCollector in Chinese patients.

Clinical Trial Description


Study Design


Related Conditions & MeSH terms

NCT number NCT03006055
Study type Interventional
Source Beijing Viroad Biotechnology Co., Ltd.
Contact YH Dong, MD
Phone +86031189928691
Email [email protected]
Status Recruiting
Phase Phase 3
Start date April 2016
Completion date December 2016